• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email
    SC 13G/A 1 d751202dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 33)*

     

     

    Oracle Corporation

    (Name of Issuer)

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    68389X105

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐

    Rule 13d-1(b)

     

      ☐

    Rule 13d-1(c)

     

      ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 68389X105

     

     1.   

     Names of Reporting Persons.

     

     Lawrence Joseph Ellison

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☐  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization:

     

     United States

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5.    

     Sole Voting Power:

     

     1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

       6.   

     Shared Voting Power:

     

     None

       7.   

     Sole Dispositive Power:

     

     1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

       8.   

     Shared Dispositive Power:

     

     None

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person:

     

     1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions):

     

     Not applicable

    11.  

     Percent of Class Represented by Amount in Row (9):

     

     41.8%

    12.  

     Type of Reporting Person (See Instructions):

     

     IN


    SCHEDULE 13G/A

    (Amendment No. 33)

    Item 1.

     

    (a)

    Name of Issuer: Oracle Corporation

     

    (b)

    Address of Issuer’s Principal Executive Offices: 2300 Oracle Way, Austin, Texas, 78741

    Item 2.

     

    (a)

    Name of Person Filing: Lawrence Joseph Ellison

     

    (b)

    Address of Principal Business Office or, if none, Residence:

    2300 Oracle Way, Austin, Texas, 78741

     

    (c)

    Citizenship: United States

     

    (d)

    Title of Class of Securities: Common Stock, par value $0.01 per share

     

    (e)

    CUSIP Number: 68389X105

     

    Item 3.

    Not applicable

     

    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned: 1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

     

      (b)

    Percent of class: 41.8%

     

      (c)

    Number of shares as to which the person has:

     

      (i)

    Sole power to vote or to direct the vote: 1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

     

      (ii)

    Shared power to vote or to direct the vote: None

     

      (iii)

    Sole power to dispose or to direct the disposition of: 1,152,982,353 (includes options to purchase 7,250,000 shares exercisable within 60 days of December 31, 2023).

     

      (iv)

    Shared power to dispose or to direct the disposition of: None

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐. Not Applicable.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.


    Item 8.

    Identification and Classification of Members of the Group. Not applicable.

     

    Item 9.

    Notice of Dissolution of Group. Not applicable.

     

    Item 10.

    Certification. Not applicable.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 9, 2024
    Signature:  

    /s/ Lawrence J. Ellison

      Lawrence J. Ellison
    Get the next $ORCL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    6/18/2025$220.00 → $250.00Buy
    Guggenheim
    6/13/2025$235.00Market Perform → Outperform
    BMO Capital Markets
    6/9/2025$175.00 → $200.00Market Perform
    BMO Capital Markets
    4/23/2025$130.00Overweight → Neutral
    Piper Sandler
    3/19/2025$167.00Equal-Weight
    Stephens
    3/11/2025$205.00 → $175.00Market Perform
    BMO Capital Markets
    3/3/2025Sell → Neutral
    Monness Crespi & Hardt
    1/17/2025$214.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Guggenheim reiterated coverage on Oracle with a new price target

      Guggenheim reiterated coverage of Oracle with a rating of Buy and set a new price target of $250.00 from $220.00 previously

      6/18/25 9:35:56 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Oracle from Market Perform to Outperform and set a new price target of $235.00

      6/13/25 7:44:59 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • BMO Capital Markets reiterated coverage on Oracle with a new price target

      BMO Capital Markets reiterated coverage of Oracle with a rating of Market Perform and set a new price target of $200.00 from $175.00 previously

      6/9/25 8:24:53 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Conrades George H sold $1,744,000 worth of shares (8,169 units at $213.49), decreasing direct ownership by 18% to 38,456 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/20/25 5:49:14 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • President, OCI Magouyrk Clayton M. sold $3,211,484 worth of shares (15,000 units at $214.10), decreasing direct ownership by 20% to 60,722 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/20/25 5:48:21 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Vice Chairman Henley Jeffrey exercised 400,000 shares at a strike of $40.36 and sold $76,169,016 worth of shares (400,000 units at $190.42) (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/13/25 4:29:29 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

      Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

      10/30/24 9:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Meharry Medical College and Oracle Collaborate to Advance Healthcare Access, Innovation, and Education

      Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th

      10/30/24 8:55:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/9/24 4:33:37 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/23 4:31:02 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/22 8:28:11 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    SEC Filings

    See more
    • SEC Form 144 filed by Oracle Corporation

      144 - ORACLE CORP (0001341439) (Subject)

      6/20/25 4:09:32 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-K filed by Oracle Corporation

      10-K - ORACLE CORP (0001341439) (Filer)

      6/18/25 4:31:22 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Oracle Corporation

      144 - ORACLE CORP (0001341439) (Subject)

      6/17/25 4:04:03 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology